| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nociceptors | 75 | 2024 | 460 | 8.730 |
Why?
|
| Pain | 111 | 2024 | 5062 | 7.780 |
Why?
|
| Ganglia, Spinal | 90 | 2024 | 525 | 7.030 |
Why?
|
| Neurons, Afferent | 72 | 2014 | 498 | 6.270 |
Why?
|
| Spinal Cord | 103 | 2024 | 1807 | 5.410 |
Why?
|
| Sensory Receptor Cells | 32 | 2024 | 508 | 5.060 |
Why?
|
| Hyperalgesia | 51 | 2024 | 526 | 4.940 |
Why?
|
| Nerve Regeneration | 46 | 2023 | 796 | 4.810 |
Why?
|
| Neuralgia | 31 | 2024 | 611 | 4.650 |
Why?
|
| Axons | 47 | 2024 | 1671 | 3.760 |
Why?
|
| Sciatic Nerve | 51 | 2021 | 618 | 3.650 |
Why?
|
| Analgesics | 29 | 2022 | 1067 | 3.620 |
Why?
|
| Posterior Horn Cells | 22 | 2024 | 87 | 3.260 |
Why?
|
| Pain Threshold | 36 | 2019 | 603 | 3.210 |
Why?
|
| Motor Neurons | 34 | 2024 | 869 | 2.550 |
Why?
|
| Peripheral Nervous System Diseases | 17 | 2024 | 709 | 2.340 |
Why?
|
| Afferent Pathways | 33 | 2014 | 298 | 2.240 |
Why?
|
| Sodium Channel Blockers | 8 | 2021 | 172 | 2.210 |
Why?
|
| Activating Transcription Factor 3 | 6 | 2021 | 58 | 2.210 |
Why?
|
| Neuronal Plasticity | 25 | 2020 | 1433 | 2.150 |
Why?
|
| Rats | 198 | 2024 | 23716 | 2.110 |
Why?
|
| Peripheral Nerves | 29 | 2014 | 479 | 2.090 |
Why?
|
| Rats, Sprague-Dawley | 106 | 2024 | 8165 | 2.070 |
Why?
|
| Inflammation | 46 | 2024 | 10759 | 1.830 |
Why?
|
| Analgesia | 12 | 2023 | 461 | 1.810 |
Why?
|
| Pain Measurement | 36 | 2022 | 3546 | 1.810 |
Why?
|
| TRPV Cation Channels | 14 | 2023 | 243 | 1.750 |
Why?
|
| Animals | 350 | 2024 | 168202 | 1.740 |
Why?
|
| Lidocaine | 12 | 2019 | 538 | 1.630 |
Why?
|
| Nerve Fibers | 39 | 2012 | 707 | 1.620 |
Why?
|
| Neurons | 51 | 2024 | 9436 | 1.590 |
Why?
|
| Synaptic Transmission | 25 | 2016 | 1169 | 1.560 |
Why?
|
| Peripheral Nervous System | 8 | 2022 | 151 | 1.410 |
Why?
|
| Nerve Growth Factors | 18 | 2003 | 564 | 1.380 |
Why?
|
| Sodium Channels | 10 | 2019 | 339 | 1.340 |
Why?
|
| Amyotrophic Lateral Sclerosis | 11 | 2021 | 1462 | 1.300 |
Why?
|
| Pruritus | 5 | 2024 | 378 | 1.290 |
Why?
|
| Sciatic Neuropathy | 7 | 2015 | 76 | 1.290 |
Why?
|
| Induced Pluripotent Stem Cells | 12 | 2024 | 1851 | 1.250 |
Why?
|
| Neuroimmunomodulation | 3 | 2024 | 184 | 1.230 |
Why?
|
| Neurites | 13 | 2022 | 391 | 1.200 |
Why?
|
| Capsaicin | 22 | 2017 | 232 | 1.180 |
Why?
|
| Neural Inhibition | 13 | 2014 | 588 | 1.160 |
Why?
|
| Behavior, Animal | 23 | 2020 | 1872 | 1.130 |
Why?
|
| Synapses | 22 | 2018 | 1754 | 1.090 |
Why?
|
| Nerve Fibers, Myelinated | 22 | 2003 | 951 | 1.070 |
Why?
|
| Mice | 107 | 2024 | 81368 | 1.060 |
Why?
|
| Morphine | 16 | 2017 | 655 | 1.060 |
Why?
|
| Physical Stimulation | 27 | 2021 | 517 | 1.010 |
Why?
|
| Central Nervous System | 16 | 2009 | 1333 | 0.990 |
Why?
|
| GTP Cyclohydrolase | 8 | 2022 | 47 | 0.960 |
Why?
|
| Gene Expression Regulation | 22 | 2022 | 11874 | 0.960 |
Why?
|
| Disease Models, Animal | 33 | 2024 | 18220 | 0.930 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 14 | 2008 | 894 | 0.930 |
Why?
|
| Hot Temperature | 14 | 2024 | 1438 | 0.920 |
Why?
|
| Schwann Cells | 6 | 2014 | 196 | 0.880 |
Why?
|
| Nerve Tissue Proteins | 26 | 2017 | 4408 | 0.870 |
Why?
|
| Somatosensory Cortex | 4 | 2024 | 512 | 0.870 |
Why?
|
| Mechanoreceptors | 16 | 2020 | 186 | 0.860 |
Why?
|
| Bradykinin | 5 | 2008 | 208 | 0.850 |
Why?
|
| Touch | 9 | 2018 | 310 | 0.840 |
Why?
|
| Reflex | 17 | 2017 | 375 | 0.800 |
Why?
|
| Mice, Inbred C57BL | 40 | 2024 | 22117 | 0.800 |
Why?
|
| Substance P | 15 | 2024 | 335 | 0.790 |
Why?
|
| Spinal Cord Injuries | 7 | 2023 | 924 | 0.790 |
Why?
|
| Vincristine | 1 | 2024 | 1036 | 0.780 |
Why?
|
| DNA Breaks | 1 | 2021 | 47 | 0.770 |
Why?
|
| Neuropeptides | 8 | 2016 | 944 | 0.760 |
Why?
|
| Spinal Nerves | 9 | 2020 | 90 | 0.760 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2021 | 106 | 0.750 |
Why?
|
| Nervous System | 6 | 2009 | 545 | 0.720 |
Why?
|
| Drug Discovery | 4 | 2021 | 1051 | 0.720 |
Why?
|
| Freund's Adjuvant | 13 | 2022 | 145 | 0.690 |
Why?
|
| Receptors, Opioid, mu | 5 | 2023 | 167 | 0.680 |
Why?
|
| Axotomy | 12 | 2020 | 71 | 0.680 |
Why?
|
| Heat-Shock Proteins | 6 | 2018 | 795 | 0.680 |
Why?
|
| Skin | 31 | 2024 | 4472 | 0.670 |
Why?
|
| Research Personnel | 1 | 2024 | 588 | 0.660 |
Why?
|
| Neuroglia | 4 | 2022 | 954 | 0.660 |
Why?
|
| Recovery of Function | 5 | 2020 | 2977 | 0.650 |
Why?
|
| Spinal Nerve Roots | 10 | 2009 | 121 | 0.650 |
Why?
|
| Hypersensitivity | 8 | 2024 | 1167 | 0.640 |
Why?
|
| Reaction Time | 12 | 2017 | 2087 | 0.640 |
Why?
|
| Neuroprotective Agents | 3 | 2024 | 957 | 0.640 |
Why?
|
| Models, Neurological | 8 | 2015 | 1768 | 0.640 |
Why?
|
| Metaplasia | 1 | 2020 | 324 | 0.630 |
Why?
|
| gamma-Aminobutyric Acid | 5 | 2016 | 1140 | 0.630 |
Why?
|
| Action Potentials | 22 | 2018 | 1825 | 0.630 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 4 | 2004 | 318 | 0.620 |
Why?
|
| Patch-Clamp Techniques | 14 | 2014 | 925 | 0.620 |
Why?
|
| Sural Nerve | 17 | 2005 | 105 | 0.610 |
Why?
|
| Anesthetics, Local | 8 | 2018 | 997 | 0.610 |
Why?
|
| Pain Perception | 2 | 2017 | 196 | 0.610 |
Why?
|
| Diltiazem | 1 | 2018 | 131 | 0.610 |
Why?
|
| Denervation | 14 | 2015 | 265 | 0.610 |
Why?
|
| Vagus Nerve | 2 | 2021 | 458 | 0.600 |
Why?
|
| Electric Stimulation | 34 | 2010 | 1734 | 0.600 |
Why?
|
| Inflammasomes | 1 | 2023 | 526 | 0.600 |
Why?
|
| Animals, Newborn | 20 | 2016 | 2669 | 0.590 |
Why?
|
| Transient Receptor Potential Channels | 6 | 2014 | 130 | 0.590 |
Why?
|
| Mucus | 1 | 2020 | 342 | 0.590 |
Why?
|
| Sensation | 7 | 2007 | 336 | 0.580 |
Why?
|
| Neurogenic Inflammation | 2 | 2019 | 33 | 0.570 |
Why?
|
| Cough | 1 | 2021 | 595 | 0.570 |
Why?
|
| Hindlimb | 19 | 2019 | 513 | 0.570 |
Why?
|
| Pain, Postoperative | 7 | 2024 | 1737 | 0.560 |
Why?
|
| Cells, Cultured | 34 | 2024 | 18937 | 0.560 |
Why?
|
| Nerve Endings | 8 | 2007 | 105 | 0.550 |
Why?
|
| Membrane Glycoproteins | 14 | 2016 | 3688 | 0.530 |
Why?
|
| Receptors, GABA-A | 5 | 2005 | 622 | 0.520 |
Why?
|
| Neural Cell Adhesion Molecules | 3 | 2005 | 122 | 0.520 |
Why?
|
| N-Methylaspartate | 7 | 2005 | 230 | 0.520 |
Why?
|
| Isoenzymes | 5 | 2004 | 1687 | 0.510 |
Why?
|
| RNA, Messenger | 23 | 2018 | 12759 | 0.510 |
Why?
|
| Sciatica | 4 | 2009 | 97 | 0.510 |
Why?
|
| Male | 165 | 2024 | 360402 | 0.510 |
Why?
|
| GAP-43 Protein | 14 | 2004 | 152 | 0.500 |
Why?
|
| Retinal Ganglion Cells | 6 | 2024 | 810 | 0.500 |
Why?
|
| Cyclooxygenase 2 | 6 | 2009 | 596 | 0.500 |
Why?
|
| Mitogen-Activated Protein Kinases | 6 | 2012 | 1242 | 0.500 |
Why?
|
| Analgesics, Opioid | 12 | 2024 | 3805 | 0.500 |
Why?
|
| Cytokines | 5 | 2024 | 7373 | 0.490 |
Why?
|
| Nerve Degeneration | 7 | 2024 | 747 | 0.490 |
Why?
|
| Humans | 177 | 2024 | 760740 | 0.490 |
Why?
|
| Immune System | 2 | 2012 | 791 | 0.480 |
Why?
|
| Up-Regulation | 13 | 2015 | 4117 | 0.470 |
Why?
|
| Antigens, Ly | 1 | 2015 | 294 | 0.470 |
Why?
|
| Mice, Knockout | 30 | 2024 | 14388 | 0.470 |
Why?
|
| Gene Expression Profiling | 9 | 2024 | 9417 | 0.460 |
Why?
|
| In Situ Hybridization | 16 | 2015 | 1900 | 0.460 |
Why?
|
| Neuromuscular Junction | 2 | 2021 | 405 | 0.460 |
Why?
|
| Airway Remodeling | 1 | 2015 | 133 | 0.460 |
Why?
|
| Aging | 10 | 2024 | 8700 | 0.450 |
Why?
|
| Ion Channels | 10 | 2016 | 1039 | 0.440 |
Why?
|
| Rats, Inbred Strains | 32 | 1992 | 2088 | 0.440 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2015 | 274 | 0.440 |
Why?
|
| Elapidae | 1 | 2013 | 4 | 0.430 |
Why?
|
| Elapid Venoms | 1 | 2013 | 40 | 0.430 |
Why?
|
| Cyclohexanecarboxylic Acids | 2 | 2004 | 140 | 0.410 |
Why?
|
| Decerebrate State | 16 | 1999 | 42 | 0.410 |
Why?
|
| Growth Cones | 6 | 2015 | 117 | 0.410 |
Why?
|
| Phenotype | 14 | 2022 | 16572 | 0.410 |
Why?
|
| Symporters | 2 | 2016 | 363 | 0.400 |
Why?
|
| Wakefulness | 3 | 2017 | 1264 | 0.400 |
Why?
|
| Trigeminal Ganglion | 3 | 2024 | 186 | 0.400 |
Why?
|
| Myelin Proteins | 2 | 2003 | 209 | 0.400 |
Why?
|
| Bupivacaine | 3 | 2019 | 411 | 0.400 |
Why?
|
| Amines | 2 | 2004 | 281 | 0.390 |
Why?
|
| Opioid-Related Disorders | 3 | 2024 | 2164 | 0.390 |
Why?
|
| Interleukin-1 | 5 | 2001 | 1248 | 0.390 |
Why?
|
| Cold Temperature | 7 | 2019 | 785 | 0.390 |
Why?
|
| Signal Transduction | 24 | 2024 | 23415 | 0.390 |
Why?
|
| Alcohol Oxidoreductases | 4 | 2019 | 168 | 0.380 |
Why?
|
| Excitatory Postsynaptic Potentials | 9 | 2005 | 369 | 0.380 |
Why?
|
| Evoked Potentials | 23 | 2001 | 1047 | 0.380 |
Why?
|
| Immunohistochemistry | 27 | 2015 | 11069 | 0.370 |
Why?
|
| Nerve Crush | 12 | 2011 | 77 | 0.370 |
Why?
|
| Receptors, Prostaglandin E | 3 | 2006 | 56 | 0.370 |
Why?
|
| Benzodiazepinones | 2 | 2008 | 50 | 0.370 |
Why?
|
| Muscles | 12 | 1993 | 1573 | 0.360 |
Why?
|
| Convulsants | 2 | 2008 | 70 | 0.360 |
Why?
|
| Myeloid Cells | 1 | 2015 | 823 | 0.360 |
Why?
|
| Mice, Transgenic | 19 | 2018 | 9526 | 0.360 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2010 | 30 | 0.360 |
Why?
|
| Nerve Block | 3 | 2014 | 705 | 0.360 |
Why?
|
| Central Nervous System Diseases | 1 | 2015 | 521 | 0.360 |
Why?
|
| Motor Activity | 5 | 2021 | 2714 | 0.350 |
Why?
|
| Sleep Deprivation | 1 | 2017 | 847 | 0.350 |
Why?
|
| Interleukins | 1 | 2015 | 783 | 0.350 |
Why?
|
| Dependovirus | 3 | 2015 | 712 | 0.350 |
Why?
|
| Calcitonin Gene-Related Peptide | 8 | 2022 | 323 | 0.340 |
Why?
|
| Fibroblasts | 4 | 2014 | 4140 | 0.330 |
Why?
|
| Valine | 2 | 2010 | 408 | 0.330 |
Why?
|
| Receptors, Opioid, delta | 1 | 2009 | 48 | 0.330 |
Why?
|
| Optic Nerve Injuries | 3 | 2022 | 150 | 0.320 |
Why?
|
| Sodium | 5 | 2023 | 1588 | 0.320 |
Why?
|
| Superoxide Dismutase | 6 | 2015 | 593 | 0.320 |
Why?
|
| Calcium Channels, L-Type | 2 | 2022 | 242 | 0.320 |
Why?
|
| Molecular Chaperones | 4 | 2011 | 754 | 0.320 |
Why?
|
| Dizocilpine Maleate | 5 | 2004 | 172 | 0.320 |
Why?
|
| Excitatory Amino Acid Antagonists | 7 | 2004 | 446 | 0.320 |
Why?
|
| Sensory Thresholds | 6 | 1996 | 377 | 0.310 |
Why?
|
| Electrophysiology | 13 | 2011 | 1262 | 0.310 |
Why?
|
| Enzyme Inhibitors | 11 | 2018 | 3705 | 0.310 |
Why?
|
| Tetrodotoxin | 6 | 2008 | 245 | 0.310 |
Why?
|
| Motor Endplate | 3 | 2011 | 20 | 0.310 |
Why?
|
| Glutamic Acid | 7 | 2005 | 1175 | 0.300 |
Why?
|
| Substantia Gelatinosa | 8 | 1999 | 11 | 0.300 |
Why?
|
| Edema | 2 | 2012 | 765 | 0.300 |
Why?
|
| Anaphylatoxins | 1 | 2007 | 21 | 0.300 |
Why?
|
| Macrophages | 6 | 2024 | 5758 | 0.300 |
Why?
|
| Cell Survival | 11 | 2015 | 5780 | 0.290 |
Why?
|
| Cell Death | 7 | 2013 | 1677 | 0.290 |
Why?
|
| Receptors, Drug | 3 | 2002 | 157 | 0.290 |
Why?
|
| Blotting, Northern | 7 | 2008 | 1545 | 0.290 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2017 | 1250 | 0.290 |
Why?
|
| Bone Morphogenetic Proteins | 4 | 2011 | 841 | 0.290 |
Why?
|
| Sulfasalazine | 2 | 2019 | 84 | 0.290 |
Why?
|
| Cell Membrane Permeability | 2 | 2007 | 574 | 0.290 |
Why?
|
| Receptors, AMPA | 3 | 2008 | 335 | 0.290 |
Why?
|
| Anterior Horn Cells | 3 | 2002 | 17 | 0.290 |
Why?
|
| Repressor Proteins | 3 | 2022 | 2985 | 0.290 |
Why?
|
| Neurofilament Proteins | 6 | 2010 | 333 | 0.290 |
Why?
|
| Complement C5a | 1 | 2007 | 100 | 0.290 |
Why?
|
| Dinoprostone | 4 | 2022 | 597 | 0.280 |
Why?
|
| Running | 1 | 2012 | 488 | 0.280 |
Why?
|
| Transcription, Genetic | 4 | 2014 | 7583 | 0.280 |
Why?
|
| Drug Evaluation, Preclinical | 4 | 2021 | 1333 | 0.280 |
Why?
|
| Gene Expression | 7 | 2021 | 7569 | 0.270 |
Why?
|
| Nerve Growth Factor | 3 | 2022 | 158 | 0.270 |
Why?
|
| Naloxone | 10 | 1995 | 370 | 0.270 |
Why?
|
| Receptors, Neurokinin-1 | 3 | 2017 | 134 | 0.270 |
Why?
|
| Receptors, Cell Surface | 5 | 2007 | 2802 | 0.260 |
Why?
|
| Time Factors | 30 | 2015 | 39908 | 0.260 |
Why?
|
| Receptors, Neurokinin-2 | 3 | 1995 | 24 | 0.260 |
Why?
|
| Receptors, GABA | 1 | 2008 | 313 | 0.260 |
Why?
|
| Growth Inhibitors | 2 | 1998 | 375 | 0.260 |
Why?
|
| Neurologic Examination | 1 | 2009 | 915 | 0.260 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2005 | 70 | 0.260 |
Why?
|
| Microglia | 4 | 2008 | 1357 | 0.260 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2015 | 3776 | 0.250 |
Why?
|
| Myelin Sheath | 3 | 2003 | 653 | 0.250 |
Why?
|
| Serotonin | 5 | 2024 | 1041 | 0.250 |
Why?
|
| Preanesthetic Medication | 2 | 1995 | 48 | 0.250 |
Why?
|
| Cell Size | 4 | 2016 | 624 | 0.250 |
Why?
|
| HSP27 Heat-Shock Proteins | 3 | 2012 | 66 | 0.250 |
Why?
|
| Injections, Spinal | 9 | 2006 | 317 | 0.250 |
Why?
|
| Protein Kinase C | 4 | 2017 | 1202 | 0.250 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 1457 | 0.240 |
Why?
|
| Caspases | 2 | 2005 | 878 | 0.240 |
Why?
|
| Calcium Signaling | 4 | 2019 | 734 | 0.240 |
Why?
|
| Hyperesthesia | 3 | 2019 | 23 | 0.240 |
Why?
|
| Acetates | 2 | 2004 | 321 | 0.240 |
Why?
|
| Isoxazoles | 2 | 2005 | 232 | 0.240 |
Why?
|
| Long-Term Potentiation | 2 | 2003 | 290 | 0.240 |
Why?
|
| Transcription Factors | 10 | 2024 | 12116 | 0.230 |
Why?
|
| Zymosan | 1 | 2024 | 134 | 0.230 |
Why?
|
| Mutation | 12 | 2023 | 30015 | 0.230 |
Why?
|
| Protein Isoforms | 6 | 2018 | 1697 | 0.230 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2004 | 361 | 0.230 |
Why?
|
| Receptors, Glutamate | 3 | 2004 | 227 | 0.220 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2004 | 112 | 0.220 |
Why?
|
| Rhizotomy | 2 | 2006 | 30 | 0.220 |
Why?
|
| Joints | 3 | 2019 | 322 | 0.220 |
Why?
|
| RGS Proteins | 1 | 2003 | 74 | 0.220 |
Why?
|
| Mechanotransduction, Cellular | 2 | 2006 | 528 | 0.220 |
Why?
|
| Excitatory Amino Acids | 1 | 2003 | 17 | 0.220 |
Why?
|
| Prostaglandins | 3 | 2002 | 398 | 0.220 |
Why?
|
| Interleukin-3 | 1 | 2024 | 425 | 0.210 |
Why?
|
| Time Perception | 1 | 2024 | 86 | 0.210 |
Why?
|
| Calcium | 9 | 2023 | 5717 | 0.210 |
Why?
|
| Single-Cell Analysis | 3 | 2024 | 2447 | 0.210 |
Why?
|
| Membrane Proteins | 9 | 2019 | 7847 | 0.210 |
Why?
|
| Phenylenediamines | 2 | 2021 | 88 | 0.210 |
Why?
|
| Thrombospondin 1 | 1 | 2024 | 257 | 0.200 |
Why?
|
| Decision Making | 1 | 2016 | 3919 | 0.200 |
Why?
|
| Female | 69 | 2024 | 392203 | 0.200 |
Why?
|
| Enzyme Activation | 8 | 2017 | 3591 | 0.200 |
Why?
|
| Cell Count | 8 | 2006 | 1834 | 0.200 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2024 | 346 | 0.200 |
Why?
|
| Simplexvirus | 2 | 2004 | 802 | 0.200 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2002 | 107 | 0.200 |
Why?
|
| Neuroma | 2 | 2023 | 133 | 0.200 |
Why?
|
| KCNQ3 Potassium Channel | 1 | 2022 | 10 | 0.200 |
Why?
|
| Blotting, Western | 8 | 2015 | 5034 | 0.200 |
Why?
|
| KCNQ2 Potassium Channel | 1 | 2022 | 19 | 0.200 |
Why?
|
| Protein Kinases | 2 | 2008 | 1606 | 0.200 |
Why?
|
| Growth Substances | 4 | 1996 | 768 | 0.200 |
Why?
|
| Sympathetic Nervous System | 3 | 2007 | 519 | 0.200 |
Why?
|
| Cell Differentiation | 9 | 2023 | 11512 | 0.200 |
Why?
|
| Heat-Shock Response | 1 | 2023 | 179 | 0.200 |
Why?
|
| Endorphins | 4 | 1983 | 74 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-fos | 3 | 2004 | 584 | 0.200 |
Why?
|
| Nerve Fibers, Unmyelinated | 5 | 2008 | 98 | 0.200 |
Why?
|
| Phantom Limb | 1 | 2023 | 98 | 0.200 |
Why?
|
| Indoles | 4 | 2013 | 1830 | 0.200 |
Why?
|
| Hallux Valgus | 1 | 2002 | 67 | 0.200 |
Why?
|
| Phosphorylases | 3 | 1987 | 17 | 0.200 |
Why?
|
| Drug Synergism | 4 | 2018 | 1756 | 0.190 |
Why?
|
| Grooming | 1 | 2021 | 38 | 0.190 |
Why?
|
| Enkephalins | 1 | 2002 | 139 | 0.190 |
Why?
|
| Dynorphins | 1 | 2002 | 82 | 0.190 |
Why?
|
| Foot | 6 | 2004 | 575 | 0.190 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 5 | 2017 | 2270 | 0.190 |
Why?
|
| Carbamates | 2 | 2021 | 191 | 0.190 |
Why?
|
| Ice | 1 | 2022 | 102 | 0.190 |
Why?
|
| Neutrophils | 3 | 2024 | 3763 | 0.190 |
Why?
|
| Apoptosis | 4 | 2005 | 9476 | 0.190 |
Why?
|
| Membrane Potentials | 8 | 2005 | 1089 | 0.190 |
Why?
|
| Low Back Pain | 2 | 2009 | 982 | 0.190 |
Why?
|
| Pluripotent Stem Cells | 2 | 2023 | 796 | 0.190 |
Why?
|
| Genetic Vectors | 5 | 2006 | 3392 | 0.180 |
Why?
|
| Alkaline Phosphatase | 1 | 2004 | 860 | 0.180 |
Why?
|
| Electrophysiological Phenomena | 3 | 2022 | 306 | 0.180 |
Why?
|
| Oral Surgical Procedures | 1 | 2002 | 166 | 0.180 |
Why?
|
| Viscera | 4 | 2005 | 138 | 0.180 |
Why?
|
| Neurobiology | 1 | 2001 | 137 | 0.180 |
Why?
|
| Chronic Disease | 7 | 2017 | 9310 | 0.180 |
Why?
|
| Serine | 1 | 2004 | 830 | 0.180 |
Why?
|
| GTPase-Activating Proteins | 1 | 2003 | 471 | 0.180 |
Why?
|
| Pterins | 1 | 2019 | 11 | 0.170 |
Why?
|
| Isoquinolines | 3 | 2008 | 352 | 0.170 |
Why?
|
| Receptors, Adrenergic | 2 | 2017 | 155 | 0.170 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2021 | 289 | 0.170 |
Why?
|
| Cannabidiol | 1 | 2022 | 118 | 0.170 |
Why?
|
| Spider Venoms | 1 | 1999 | 43 | 0.170 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 4242 | 0.170 |
Why?
|
| Calcium Channels, N-Type | 1 | 2019 | 43 | 0.170 |
Why?
|
| Demyelinating Diseases | 1 | 2022 | 352 | 0.170 |
Why?
|
| Protein Precursors | 2 | 2002 | 1131 | 0.170 |
Why?
|
| Guinea Pigs | 1 | 2021 | 1310 | 0.170 |
Why?
|
| Mustard Plant | 6 | 1998 | 13 | 0.170 |
Why?
|
| Thermosensing | 3 | 2010 | 55 | 0.160 |
Why?
|
| T-Lymphocytes | 5 | 2018 | 10175 | 0.160 |
Why?
|
| Receptors, IgE | 1 | 2021 | 375 | 0.160 |
Why?
|
| Horseradish Peroxidase | 6 | 1997 | 166 | 0.160 |
Why?
|
| Carrier Proteins | 4 | 2011 | 4937 | 0.160 |
Why?
|
| GTP-Binding Proteins | 1 | 2003 | 949 | 0.160 |
Why?
|
| Cell Cycle Proteins | 2 | 2017 | 3447 | 0.160 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2006 | 3606 | 0.160 |
Why?
|
| Drug Design | 3 | 2017 | 1045 | 0.160 |
Why?
|
| Tuberous Sclerosis | 2 | 2018 | 1031 | 0.160 |
Why?
|
| NAD | 1 | 2022 | 614 | 0.160 |
Why?
|
| Calcium Channel Blockers | 2 | 2019 | 694 | 0.160 |
Why?
|
| Receptors, Amino Acid | 3 | 1994 | 30 | 0.150 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2018 | 141 | 0.150 |
Why?
|
| Plant Oils | 6 | 1998 | 198 | 0.150 |
Why?
|
| Cerebral Cortex | 3 | 2024 | 5776 | 0.150 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2017 | 1133 | 0.150 |
Why?
|
| Ovalbumin | 2 | 2021 | 675 | 0.150 |
Why?
|
| Serine C-Palmitoyltransferase | 2 | 2009 | 42 | 0.150 |
Why?
|
| Hair | 6 | 2021 | 498 | 0.150 |
Why?
|
| Glutamates | 3 | 1988 | 389 | 0.150 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 13383 | 0.150 |
Why?
|
| Hereditary Sensory and Autonomic Neuropathies | 2 | 2009 | 41 | 0.150 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 3 | 2005 | 321 | 0.150 |
Why?
|
| Interneurons | 5 | 2024 | 582 | 0.150 |
Why?
|
| Mice, Inbred C3H | 3 | 2015 | 913 | 0.150 |
Why?
|
| GPI-Linked Proteins | 5 | 2011 | 469 | 0.150 |
Why?
|
| Temperature | 4 | 2011 | 2224 | 0.150 |
Why?
|
| Pharmaceutical Preparations | 2 | 2020 | 1086 | 0.150 |
Why?
|
| Drug Tolerance | 1 | 2019 | 367 | 0.140 |
Why?
|
| Cell Communication | 2 | 2016 | 1654 | 0.140 |
Why?
|
| Sensory Gating | 1 | 2017 | 47 | 0.140 |
Why?
|
| Arthritis, Experimental | 1 | 2019 | 291 | 0.140 |
Why?
|
| Respiratory Mucosa | 1 | 2021 | 438 | 0.140 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2017 | 57 | 0.140 |
Why?
|
| Homeodomain Proteins | 2 | 2004 | 2413 | 0.140 |
Why?
|
| Receptor, trkA | 4 | 2006 | 159 | 0.140 |
Why?
|
| Mast Cells | 1 | 2024 | 1392 | 0.140 |
Why?
|
| Calcium-Binding Proteins | 1 | 2002 | 1066 | 0.140 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 3 | 2007 | 66 | 0.140 |
Why?
|
| Muscle Denervation | 2 | 1993 | 60 | 0.140 |
Why?
|
| Stimulation, Chemical | 6 | 2004 | 306 | 0.140 |
Why?
|
| Antirheumatic Agents | 2 | 2019 | 1365 | 0.140 |
Why?
|
| Aspartic Acid | 3 | 1988 | 576 | 0.140 |
Why?
|
| Brain Mapping | 5 | 2021 | 6635 | 0.140 |
Why?
|
| Cholera Toxin | 5 | 1998 | 559 | 0.140 |
Why?
|
| Palliative Care | 3 | 2000 | 3593 | 0.140 |
Why?
|
| Staphylococcal Infections | 2 | 2018 | 1406 | 0.140 |
Why?
|
| Neural Conduction | 6 | 2012 | 441 | 0.140 |
Why?
|
| Pyramidal Tracts | 1 | 2018 | 251 | 0.140 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2004 | 602 | 0.140 |
Why?
|
| Injections | 5 | 2014 | 832 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 10 | 2021 | 10754 | 0.140 |
Why?
|
| Electric Conductivity | 5 | 2007 | 405 | 0.130 |
Why?
|
| Ligation | 4 | 2005 | 446 | 0.130 |
Why?
|
| Sulfonamides | 2 | 2005 | 1977 | 0.130 |
Why?
|
| Dogs | 1 | 2021 | 3837 | 0.130 |
Why?
|
| Corticosterone | 1 | 2017 | 305 | 0.130 |
Why?
|
| Purkinje Cells | 1 | 2018 | 226 | 0.130 |
Why?
|
| Esophagus | 6 | 2006 | 1031 | 0.130 |
Why?
|
| Video Recording | 1 | 2021 | 965 | 0.130 |
Why?
|
| Chemoreceptor Cells | 2 | 1994 | 89 | 0.130 |
Why?
|
| Glycoproteins | 2 | 2003 | 2200 | 0.130 |
Why?
|
| Nucleosomes | 1 | 2019 | 487 | 0.130 |
Why?
|
| Receptors, Opioid | 5 | 2023 | 145 | 0.130 |
Why?
|
| Cytoplasmic Granules | 1 | 2018 | 573 | 0.130 |
Why?
|
| Amides | 1 | 2018 | 449 | 0.130 |
Why?
|
| 2-Amino-5-phosphonovalerate | 5 | 2000 | 57 | 0.130 |
Why?
|
| Memory | 2 | 2003 | 2192 | 0.130 |
Why?
|
| Ibuprofen | 1 | 2017 | 229 | 0.130 |
Why?
|
| Cell Separation | 3 | 2017 | 1718 | 0.130 |
Why?
|
| Irritants | 1 | 1995 | 43 | 0.120 |
Why?
|
| Organoplatinum Compounds | 1 | 2017 | 407 | 0.120 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 2 | 2012 | 64 | 0.120 |
Why?
|
| Plant Extracts | 6 | 1998 | 497 | 0.120 |
Why?
|
| Immunoglobulin E | 1 | 2021 | 1502 | 0.120 |
Why?
|
| Lymphokines | 1 | 1998 | 925 | 0.120 |
Why?
|
| Cell Culture Techniques | 2 | 2014 | 1662 | 0.120 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2019 | 634 | 0.120 |
Why?
|
| Benzoates | 1 | 2016 | 212 | 0.120 |
Why?
|
| Muscle, Skeletal | 5 | 2014 | 4947 | 0.120 |
Why?
|
| Wounds and Injuries | 5 | 2007 | 2492 | 0.120 |
Why?
|
| Social Behavior | 1 | 2021 | 1135 | 0.120 |
Why?
|
| Gelsolin | 1 | 2015 | 189 | 0.120 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 2015 | 179 | 0.120 |
Why?
|
| Immunity, Innate | 2 | 2020 | 3045 | 0.120 |
Why?
|
| Tubulin | 1 | 2018 | 692 | 0.120 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2014 | 411 | 0.120 |
Why?
|
| Interleukin-5 | 1 | 2015 | 269 | 0.120 |
Why?
|
| beta-Endorphin | 1 | 2014 | 43 | 0.120 |
Why?
|
| Receptors, Glycine | 1 | 1994 | 32 | 0.120 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 1745 | 0.120 |
Why?
|
| Osteoarthritis, Knee | 2 | 2016 | 1234 | 0.120 |
Why?
|
| Leukocyte Elastase | 1 | 2015 | 114 | 0.120 |
Why?
|
| Protein Subunits | 3 | 2009 | 942 | 0.120 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 370 | 0.120 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2019 | 725 | 0.120 |
Why?
|
| Receptors, Nerve Growth Factor | 3 | 2002 | 198 | 0.120 |
Why?
|
| Adaptation, Physiological | 2 | 2009 | 1300 | 0.110 |
Why?
|
| Mice, Inbred DBA | 1 | 2015 | 619 | 0.110 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2016 | 412 | 0.110 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2005 | 614 | 0.110 |
Why?
|
| Drosophila | 2 | 2012 | 1494 | 0.110 |
Why?
|
| Lactones | 2 | 2009 | 316 | 0.110 |
Why?
|
| Receptors, Growth Factor | 2 | 2005 | 326 | 0.110 |
Why?
|
| Peptides | 3 | 2012 | 4354 | 0.110 |
Why?
|
| Acute-Phase Proteins | 1 | 2015 | 250 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2004 | 2747 | 0.110 |
Why?
|
| Dysautonomia, Familial | 1 | 2014 | 94 | 0.110 |
Why?
|
| Sulfones | 2 | 2009 | 447 | 0.110 |
Why?
|
| Histamine Agonists | 1 | 2013 | 13 | 0.110 |
Why?
|
| Skin Diseases | 1 | 2022 | 1094 | 0.110 |
Why?
|
| Microtubules | 2 | 2018 | 1073 | 0.110 |
Why?
|
| Molecular Sequence Data | 10 | 2006 | 17630 | 0.110 |
Why?
|
| RNA, Transfer, Tyr | 1 | 2013 | 4 | 0.110 |
Why?
|
| Dendritic Spines | 1 | 2015 | 242 | 0.110 |
Why?
|
| Gyrus Cinguli | 1 | 2020 | 1115 | 0.110 |
Why?
|
| Antipruritics | 1 | 2013 | 31 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 2 | 1999 | 1971 | 0.110 |
Why?
|
| Serpins | 1 | 2015 | 247 | 0.110 |
Why?
|
| Electromyography | 2 | 2017 | 1392 | 0.110 |
Why?
|
| Fever | 7 | 1980 | 1618 | 0.110 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2013 | 221 | 0.110 |
Why?
|
| Thalamus | 1 | 2020 | 1047 | 0.110 |
Why?
|
| Hemolysin Proteins | 1 | 2013 | 113 | 0.110 |
Why?
|
| Electrodes, Implanted | 1 | 2018 | 838 | 0.110 |
Why?
|
| Light Signal Transduction | 1 | 2013 | 31 | 0.110 |
Why?
|
| Thermogenesis | 1 | 2017 | 474 | 0.110 |
Why?
|
| Bacterial Load | 1 | 2013 | 151 | 0.110 |
Why?
|
| Bacterial Toxins | 2 | 2018 | 925 | 0.110 |
Why?
|
| Phosphorylation | 7 | 2014 | 8311 | 0.100 |
Why?
|
| Chloride Channels | 1 | 2014 | 221 | 0.100 |
Why?
|
| Models, Biological | 4 | 2018 | 9461 | 0.100 |
Why?
|
| Hydrochloric Acid | 5 | 2006 | 76 | 0.100 |
Why?
|
| Isoindoles | 3 | 1998 | 35 | 0.100 |
Why?
|
| Photochemical Processes | 1 | 2013 | 86 | 0.100 |
Why?
|
| Neural Pathways | 3 | 2018 | 3056 | 0.100 |
Why?
|
| Premedication | 1 | 1993 | 245 | 0.100 |
Why?
|
| Caffeine | 1 | 2017 | 699 | 0.100 |
Why?
|
| Cell Line | 6 | 2019 | 15577 | 0.100 |
Why?
|
| Conditioning, Classical | 1 | 1995 | 368 | 0.100 |
Why?
|
| Axonal Transport | 4 | 1999 | 178 | 0.100 |
Why?
|
| Spinal Injuries | 1 | 1995 | 300 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 15829 | 0.100 |
Why?
|
| Amino Acid Sequence | 8 | 2019 | 13442 | 0.100 |
Why?
|
| Endometriosis | 1 | 2020 | 857 | 0.100 |
Why?
|
| Foot Injuries | 1 | 2014 | 149 | 0.100 |
Why?
|
| Zinc | 1 | 1996 | 687 | 0.100 |
Why?
|
| Electrical Synapses | 1 | 2011 | 18 | 0.100 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2012 | 86 | 0.100 |
Why?
|
| Ion Transport | 1 | 2013 | 320 | 0.100 |
Why?
|
| Analysis of Variance | 5 | 2012 | 6223 | 0.100 |
Why?
|
| Drosophila Proteins | 2 | 2011 | 1698 | 0.100 |
Why?
|
| Lymphatic Diseases | 1 | 2013 | 320 | 0.100 |
Why?
|
| Hysterectomy | 2 | 1995 | 856 | 0.100 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 943 | 0.100 |
Why?
|
| Neurotoxins | 1 | 1992 | 240 | 0.100 |
Why?
|
| Staining and Labeling | 4 | 2000 | 1081 | 0.100 |
Why?
|
| Muscle Contraction | 4 | 1995 | 1200 | 0.100 |
Why?
|
| Protein Stability | 1 | 2013 | 578 | 0.100 |
Why?
|
| Trigeminal Nuclei | 2 | 1981 | 39 | 0.100 |
Why?
|
| Phosphoproteins | 3 | 2016 | 2445 | 0.090 |
Why?
|
| Chemokines | 1 | 2015 | 954 | 0.090 |
Why?
|
| Histamine | 1 | 2013 | 499 | 0.090 |
Why?
|
| Clinical Trials as Topic | 4 | 2015 | 7995 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2016 | 1169 | 0.090 |
Why?
|
| Aplysia | 1 | 1991 | 40 | 0.090 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2013 | 345 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 2 | 1998 | 1810 | 0.090 |
Why?
|
| Benzimidazoles | 1 | 2016 | 858 | 0.090 |
Why?
|
| Efferent Pathways | 2 | 1983 | 165 | 0.090 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 697 | 0.090 |
Why?
|
| TRPC Cation Channels | 1 | 2011 | 111 | 0.090 |
Why?
|
| Epoxide Hydrolases | 1 | 2011 | 122 | 0.090 |
Why?
|
| Lumbar Vertebrae | 1 | 2020 | 1874 | 0.090 |
Why?
|
| Mice, Inbred NOD | 1 | 2015 | 1827 | 0.090 |
Why?
|
| Biophysics | 2 | 2009 | 379 | 0.090 |
Why?
|
| Thermoreceptors | 4 | 1984 | 27 | 0.090 |
Why?
|
| Substance-Related Disorders | 2 | 2017 | 4416 | 0.090 |
Why?
|
| Genes, Reporter | 2 | 2005 | 1525 | 0.090 |
Why?
|
| Cricetinae | 5 | 2022 | 2424 | 0.090 |
Why?
|
| Neoplasm Proteins | 1 | 2002 | 3607 | 0.090 |
Why?
|
| Benzhydryl Compounds | 1 | 2017 | 915 | 0.090 |
Why?
|
| Nervous System Diseases | 1 | 2001 | 1662 | 0.090 |
Why?
|
| RNA-Binding Proteins | 2 | 2016 | 1890 | 0.090 |
Why?
|
| DNA-Binding Proteins | 5 | 2019 | 9586 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2015 | 2063 | 0.080 |
Why?
|
| Tibial Nerve | 4 | 2005 | 50 | 0.080 |
Why?
|
| Arthralgia | 1 | 2013 | 461 | 0.080 |
Why?
|
| Nuclear Proteins | 2 | 2006 | 5789 | 0.080 |
Why?
|
| Ion Channel Gating | 4 | 2007 | 429 | 0.080 |
Why?
|
| Drug Prescriptions | 2 | 2013 | 1669 | 0.080 |
Why?
|
| Autonomic Fibers, Preganglionic | 1 | 2009 | 8 | 0.080 |
Why?
|
| Patents as Topic | 1 | 2010 | 111 | 0.080 |
Why?
|
| Electronarcosis | 2 | 1979 | 3 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 3 | 2006 | 1962 | 0.080 |
Why?
|
| Cyclic AMP | 4 | 1987 | 1463 | 0.080 |
Why?
|
| Pyridines | 3 | 2018 | 2875 | 0.080 |
Why?
|
| Acute Disease | 4 | 2017 | 7236 | 0.080 |
Why?
|
| Reproducibility of Results | 6 | 2021 | 20077 | 0.080 |
Why?
|
| Cobalt | 3 | 1994 | 154 | 0.080 |
Why?
|
| Neuralgia, Postherpetic | 1 | 2009 | 41 | 0.080 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2013 | 584 | 0.080 |
Why?
|
| Paclitaxel | 1 | 2016 | 1730 | 0.080 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 1982 | 540 | 0.080 |
Why?
|
| Transfection | 5 | 2015 | 5765 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2017 | 485 | 0.080 |
Why?
|
| Phospholipids | 1 | 2012 | 787 | 0.080 |
Why?
|
| Haplotypes | 4 | 2008 | 2713 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 4570 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2021 | 8998 | 0.080 |
Why?
|
| Plants, Medicinal | 3 | 1995 | 165 | 0.080 |
Why?
|
| Behavior, Addictive | 1 | 2014 | 462 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2016 | 1650 | 0.080 |
Why?
|
| Rabbits | 10 | 2000 | 4770 | 0.080 |
Why?
|
| Drug Interactions | 1 | 2013 | 1415 | 0.080 |
Why?
|
| Glaucoma | 1 | 2018 | 1186 | 0.080 |
Why?
|
| Drug Delivery Systems | 2 | 2011 | 2222 | 0.080 |
Why?
|
| Marketing | 1 | 2010 | 220 | 0.080 |
Why?
|
| Oxadiazoles | 1 | 1988 | 94 | 0.080 |
Why?
|
| CHO Cells | 4 | 2022 | 1387 | 0.080 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 4745 | 0.080 |
Why?
|
| Interleukin-6 | 1 | 1998 | 3205 | 0.080 |
Why?
|
| Bone Morphogenetic Protein Receptors | 2 | 2005 | 46 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2024 | 4642 | 0.080 |
Why?
|
| Embryo, Mammalian | 4 | 2013 | 1670 | 0.080 |
Why?
|
| Research Design | 4 | 2016 | 6174 | 0.080 |
Why?
|
| Sphingolipids | 1 | 2009 | 173 | 0.080 |
Why?
|
| Drosophila melanogaster | 2 | 2021 | 1712 | 0.080 |
Why?
|
| Smad1 Protein | 2 | 2005 | 81 | 0.080 |
Why?
|
| Actins | 1 | 2015 | 2051 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2002 | 638 | 0.070 |
Why?
|
| Calcium Channels | 2 | 2010 | 620 | 0.070 |
Why?
|
| Autoimmunity | 1 | 2016 | 1350 | 0.070 |
Why?
|
| Receptors, Tachykinin | 2 | 1998 | 25 | 0.070 |
Why?
|
| Skin Physiological Phenomena | 2 | 1986 | 188 | 0.070 |
Why?
|
| Smad Proteins | 2 | 2005 | 156 | 0.070 |
Why?
|
| Cluster Analysis | 1 | 2014 | 2703 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2017 | 10203 | 0.070 |
Why?
|
| Nerve Compression Syndromes | 1 | 2009 | 160 | 0.070 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 3680 | 0.070 |
Why?
|
| Microscopy, Electron | 6 | 2003 | 2561 | 0.070 |
Why?
|
| Brain Stem | 2 | 1984 | 858 | 0.070 |
Why?
|
| Small Molecule Libraries | 1 | 2013 | 733 | 0.070 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2007 | 87 | 0.070 |
Why?
|
| Vibrissae | 1 | 2008 | 116 | 0.070 |
Why?
|
| Pyrogens | 6 | 1980 | 17 | 0.070 |
Why?
|
| Decision Trees | 1 | 2009 | 504 | 0.070 |
Why?
|
| Neural Stem Cells | 1 | 2014 | 887 | 0.070 |
Why?
|
| Autonomic Nervous System | 1 | 2012 | 704 | 0.070 |
Why?
|
| Ligands | 2 | 2022 | 3268 | 0.070 |
Why?
|
| Cross-Cultural Comparison | 1 | 2010 | 634 | 0.070 |
Why?
|
| Tissue Engineering | 2 | 2021 | 1865 | 0.070 |
Why?
|
| Receptors, Complement | 1 | 2007 | 253 | 0.070 |
Why?
|
| Double-Blind Method | 6 | 2021 | 12333 | 0.070 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 2006 | 44 | 0.070 |
Why?
|
| Embryo, Nonmammalian | 2 | 2013 | 905 | 0.070 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 3 | 2008 | 682 | 0.070 |
Why?
|
| Embryonic Development | 2 | 2011 | 720 | 0.070 |
Why?
|
| Zebrafish Proteins | 1 | 2013 | 1013 | 0.070 |
Why?
|
| Cognition | 1 | 2024 | 6988 | 0.070 |
Why?
|
| Microelectrodes | 2 | 2001 | 306 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 2018 | 2238 | 0.070 |
Why?
|
| Voltage-Dependent Anion Channels | 1 | 2006 | 15 | 0.070 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2007 | 137 | 0.070 |
Why?
|
| Turpentine | 2 | 1996 | 10 | 0.070 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2005 | 19 | 0.070 |
Why?
|
| Cloning, Molecular | 4 | 2005 | 4172 | 0.060 |
Why?
|
| Receptor, Bradykinin B2 | 1 | 2005 | 24 | 0.060 |
Why?
|
| Caspase 3 | 2 | 2012 | 731 | 0.060 |
Why?
|
| Acids | 2 | 2004 | 125 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 2 | 2003 | 3793 | 0.060 |
Why?
|
| Radiculopathy | 1 | 2008 | 201 | 0.060 |
Why?
|
| Disease Susceptibility | 2 | 2024 | 1788 | 0.060 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2005 | 68 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1997 | 4340 | 0.060 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2012 | 1117 | 0.060 |
Why?
|
| Astrocytes | 2 | 2005 | 1341 | 0.060 |
Why?
|
| Embryonic Stem Cells | 1 | 2013 | 1262 | 0.060 |
Why?
|
| Dendrites | 4 | 2011 | 471 | 0.060 |
Why?
|
| Chest Pain | 2 | 2004 | 1091 | 0.060 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2007 | 311 | 0.060 |
Why?
|
| Adipose Tissue | 1 | 2017 | 3310 | 0.060 |
Why?
|
| Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate | 2 | 1997 | 35 | 0.060 |
Why?
|
| Reflex, Abnormal | 1 | 1985 | 83 | 0.060 |
Why?
|
| Facial Nerve | 1 | 2008 | 277 | 0.060 |
Why?
|
| Linkage Disequilibrium | 1 | 2010 | 1994 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2006 | 287 | 0.060 |
Why?
|
| Diabetic Neuropathies | 1 | 2009 | 405 | 0.060 |
Why?
|
| Cesium | 2 | 2013 | 36 | 0.060 |
Why?
|
| Anesthesia, Local | 1 | 2007 | 277 | 0.060 |
Why?
|
| Transgenes | 2 | 2023 | 1008 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2008 | 705 | 0.060 |
Why?
|
| Presynaptic Terminals | 1 | 2007 | 302 | 0.060 |
Why?
|
| Species Specificity | 2 | 2024 | 2410 | 0.060 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2005 | 292 | 0.060 |
Why?
|
| Neural Crest | 1 | 2007 | 278 | 0.060 |
Why?
|
| Allergens | 2 | 2024 | 1429 | 0.060 |
Why?
|
| RNA, Small Interfering | 3 | 2015 | 3419 | 0.060 |
Why?
|
| Comprehension | 1 | 2010 | 620 | 0.060 |
Why?
|
| Cannabinoids | 1 | 2007 | 172 | 0.060 |
Why?
|
| Microscopy, Immunoelectron | 2 | 1997 | 317 | 0.060 |
Why?
|
| Homeostasis | 1 | 2016 | 3321 | 0.060 |
Why?
|
| HEK293 Cells | 3 | 2019 | 4269 | 0.060 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 1454 | 0.060 |
Why?
|
| Quinoxalines | 2 | 2000 | 296 | 0.060 |
Why?
|
| Base Sequence | 3 | 2004 | 12420 | 0.060 |
Why?
|
| Intermediate Filament Proteins | 2 | 2008 | 262 | 0.060 |
Why?
|
| Parkinson Disease | 1 | 2018 | 2878 | 0.060 |
Why?
|
| Indoleacetic Acids | 1 | 2004 | 44 | 0.060 |
Why?
|
| Histocytochemistry | 3 | 1996 | 696 | 0.060 |
Why?
|
| Prostaglandins E | 5 | 1977 | 166 | 0.060 |
Why?
|
| Reflex, Stretch | 1 | 1984 | 23 | 0.060 |
Why?
|
| Nuclease Protection Assays | 1 | 2004 | 14 | 0.060 |
Why?
|
| Body Temperature Regulation | 2 | 1977 | 292 | 0.060 |
Why?
|
| Raphe Nuclei | 2 | 1981 | 103 | 0.060 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2024 | 94 | 0.060 |
Why?
|
| Syndrome | 1 | 2010 | 3268 | 0.060 |
Why?
|
| Flow Cytometry | 1 | 2014 | 5863 | 0.060 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2004 | 126 | 0.060 |
Why?
|
| Omeprazole | 1 | 2004 | 105 | 0.060 |
Why?
|
| Cricetulus | 2 | 2022 | 814 | 0.060 |
Why?
|
| Tritium | 1 | 2004 | 706 | 0.060 |
Why?
|
| Monocytes | 1 | 2013 | 2565 | 0.060 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2004 | 90 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2019 | 2916 | 0.060 |
Why?
|
| Gene Regulatory Networks | 1 | 2012 | 1745 | 0.060 |
Why?
|
| Melanoma | 1 | 2022 | 5696 | 0.060 |
Why?
|
| Dialysis Solutions | 1 | 2004 | 34 | 0.060 |
Why?
|
| Analgesia, Patient-Controlled | 2 | 1995 | 113 | 0.060 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2006 | 352 | 0.060 |
Why?
|
| STAT5 Transcription Factor | 1 | 2024 | 265 | 0.060 |
Why?
|
| Microdialysis | 1 | 2004 | 161 | 0.060 |
Why?
|
| Age Factors | 6 | 2012 | 18381 | 0.060 |
Why?
|
| Norepinephrine | 3 | 1975 | 898 | 0.060 |
Why?
|
| GABA Antagonists | 1 | 2003 | 119 | 0.060 |
Why?
|
| Autoradiography | 1 | 2004 | 728 | 0.050 |
Why?
|
| Brain | 5 | 2022 | 27100 | 0.050 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2006 | 358 | 0.050 |
Why?
|
| Drug Approval | 1 | 2010 | 812 | 0.050 |
Why?
|
| GABA Agonists | 1 | 2003 | 104 | 0.050 |
Why?
|
| Hair Cells, Auditory | 1 | 2006 | 381 | 0.050 |
Why?
|
| Ribonucleases | 1 | 2004 | 277 | 0.050 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2018 | 2057 | 0.050 |
Why?
|
| Opioid Peptides | 1 | 2022 | 37 | 0.050 |
Why?
|
| Biomedical Research | 3 | 2015 | 3426 | 0.050 |
Why?
|
| Body Patterning | 2 | 2005 | 632 | 0.050 |
Why?
|
| Genes, RAG-1 | 1 | 2022 | 67 | 0.050 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2007 | 620 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 998 | 0.050 |
Why?
|
| Tibial Neuropathy | 1 | 2002 | 4 | 0.050 |
Why?
|
| Atlases as Topic | 1 | 2024 | 247 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 4 | 2015 | 6074 | 0.050 |
Why?
|
| Lung | 2 | 2020 | 9999 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 2872 | 0.050 |
Why?
|
| Biological Products | 1 | 2012 | 912 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2005 | 851 | 0.050 |
Why?
|
| Osmolar Concentration | 1 | 2004 | 659 | 0.050 |
Why?
|
| Biphenyl Compounds | 2 | 2006 | 1007 | 0.050 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2002 | 48 | 0.050 |
Why?
|
| Cytochrome c Group | 1 | 2002 | 122 | 0.050 |
Why?
|
| Receptors, Prostaglandin | 1 | 2002 | 53 | 0.050 |
Why?
|
| Sensitivity and Specificity | 3 | 2009 | 14649 | 0.050 |
Why?
|
| Adult | 22 | 2019 | 220995 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2004 | 550 | 0.050 |
Why?
|
| Acetyltransferases | 1 | 2003 | 231 | 0.050 |
Why?
|
| Blood Pressure | 3 | 2015 | 8473 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2002 | 3730 | 0.050 |
Why?
|
| Cyclooxygenase 1 | 1 | 2002 | 97 | 0.050 |
Why?
|
| Molar, Third | 1 | 2002 | 53 | 0.050 |
Why?
|
| Drug Therapy, Combination | 2 | 2009 | 6305 | 0.050 |
Why?
|
| S100 Proteins | 2 | 1993 | 217 | 0.050 |
Why?
|
| Macaca | 1 | 2023 | 410 | 0.050 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2002 | 40 | 0.050 |
Why?
|
| Formaldehyde | 2 | 2003 | 357 | 0.050 |
Why?
|
| Amino Acids | 1 | 1988 | 1718 | 0.050 |
Why?
|
| Xenopus Proteins | 1 | 2005 | 434 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2022 | 36401 | 0.050 |
Why?
|
| Butadienes | 1 | 2002 | 107 | 0.050 |
Why?
|
| Critical Illness | 1 | 2015 | 2709 | 0.050 |
Why?
|
| src-Family Kinases | 1 | 2004 | 535 | 0.050 |
Why?
|
| Mesencephalon | 2 | 2000 | 333 | 0.050 |
Why?
|
| Integrases | 2 | 2020 | 518 | 0.050 |
Why?
|
| Phospholipases A | 1 | 2002 | 204 | 0.050 |
Why?
|
| Gangliosides | 1 | 2002 | 132 | 0.050 |
Why?
|
| Heterozygote | 3 | 2019 | 2780 | 0.050 |
Why?
|
| Organ Specificity | 2 | 2004 | 1964 | 0.050 |
Why?
|
| Drug Industry | 1 | 2008 | 788 | 0.050 |
Why?
|
| Learning | 2 | 2006 | 1740 | 0.050 |
Why?
|
| Stress, Mechanical | 2 | 1998 | 1674 | 0.050 |
Why?
|
| Pharmacology, Clinical | 1 | 2001 | 22 | 0.050 |
Why?
|
| Melanocyte-Stimulating Hormones | 1 | 2021 | 25 | 0.050 |
Why?
|
| Epidermis | 1 | 2024 | 526 | 0.050 |
Why?
|
| Glutamate Decarboxylase | 1 | 2002 | 239 | 0.050 |
Why?
|
| Electroencephalography | 1 | 2017 | 6240 | 0.050 |
Why?
|
| Paresthesia | 1 | 2022 | 162 | 0.050 |
Why?
|
| Proteomics | 1 | 2015 | 3836 | 0.050 |
Why?
|
| Cation Exchange Resins | 1 | 2001 | 19 | 0.050 |
Why?
|
| RNA Interference | 2 | 2010 | 2829 | 0.050 |
Why?
|
| Biology | 1 | 2023 | 290 | 0.050 |
Why?
|
| Pharmacists | 1 | 2004 | 259 | 0.050 |
Why?
|
| Exons | 3 | 2016 | 2381 | 0.050 |
Why?
|
| Leg | 3 | 1996 | 1087 | 0.050 |
Why?
|
| Light | 2 | 2020 | 1352 | 0.050 |
Why?
|
| Janus Kinase 2 | 1 | 2024 | 560 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 1996 | 412 | 0.050 |
Why?
|
| Tooth Extraction | 1 | 2002 | 229 | 0.050 |
Why?
|
| Methotrexate | 1 | 2008 | 1716 | 0.050 |
Why?
|
| Receptor, Melanocortin, Type 1 | 1 | 2021 | 74 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2002 | 1141 | 0.050 |
Why?
|
| Morphogenesis | 1 | 2005 | 741 | 0.050 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2002 | 276 | 0.050 |
Why?
|
| Professional Role | 1 | 2004 | 313 | 0.050 |
Why?
|
| Arginine Vasopressin | 1 | 1981 | 125 | 0.050 |
Why?
|
| Trans-Activators | 3 | 2005 | 2851 | 0.050 |
Why?
|
| Arachidonic Acid | 1 | 2002 | 427 | 0.050 |
Why?
|
| Parents | 1 | 2015 | 3563 | 0.050 |
Why?
|
| Xenopus laevis | 1 | 2005 | 963 | 0.050 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2002 | 138 | 0.050 |
Why?
|
| Eye Movements | 1 | 2024 | 511 | 0.050 |
Why?
|
| Pain, Intractable | 1 | 2001 | 132 | 0.040 |
Why?
|
| Peroneal Nerve | 3 | 2005 | 76 | 0.040 |
Why?
|
| Multigene Family | 1 | 2004 | 1076 | 0.040 |
Why?
|
| Connexins | 2 | 2013 | 352 | 0.040 |
Why?
|
| Expressed Sequence Tags | 1 | 2001 | 250 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2004 | 1162 | 0.040 |
Why?
|
| Enzyme Induction | 1 | 2001 | 452 | 0.040 |
Why?
|
| Meglumine | 1 | 2001 | 143 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 2016 | 2100 | 0.040 |
Why?
|
| Dental Pulp | 1 | 1981 | 84 | 0.040 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2021 | 129 | 0.040 |
Why?
|
| Evans Blue | 2 | 1998 | 42 | 0.040 |
Why?
|
| DNA Primers | 2 | 2007 | 2817 | 0.040 |
Why?
|
| Receptors, Presynaptic | 1 | 2000 | 15 | 0.040 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 1999 | 1626 | 0.040 |
Why?
|
| Bucladesine | 5 | 1987 | 118 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2014 | 1074 | 0.040 |
Why?
|
| Protein Binding | 2 | 2019 | 9345 | 0.040 |
Why?
|
| Delayed-Action Preparations | 1 | 2004 | 962 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 2 | 2018 | 1608 | 0.040 |
Why?
|
| Semaphorin-3A | 1 | 1999 | 39 | 0.040 |
Why?
|
| Receptor, Ciliary Neurotrophic Factor | 1 | 1999 | 36 | 0.040 |
Why?
|
| Anxiety | 1 | 2015 | 4573 | 0.040 |
Why?
|
| Cerebellum | 2 | 2018 | 1501 | 0.040 |
Why?
|
| Hypothalamus | 6 | 1980 | 999 | 0.040 |
Why?
|
| Proteins | 2 | 2005 | 6030 | 0.040 |
Why?
|
| Pons | 1 | 2000 | 240 | 0.040 |
Why?
|
| Sensation Disorders | 1 | 2000 | 160 | 0.040 |
Why?
|
| Physicians | 2 | 2010 | 4583 | 0.040 |
Why?
|
| Proton Pump Inhibitors | 1 | 2004 | 533 | 0.040 |
Why?
|
| Genotype | 2 | 2012 | 12977 | 0.040 |
Why?
|
| Amidines | 1 | 1999 | 29 | 0.040 |
Why?
|
| Melanoma, Experimental | 1 | 2022 | 561 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2003 | 1096 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 1999 | 237 | 0.040 |
Why?
|
| Culture Techniques | 1 | 1999 | 531 | 0.040 |
Why?
|
| Thapsigargin | 1 | 2018 | 102 | 0.040 |
Why?
|
| Trigeminal Neuralgia | 1 | 2000 | 107 | 0.040 |
Why?
|
| United States | 2 | 2024 | 72292 | 0.040 |
Why?
|
| Toes | 2 | 1993 | 209 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2022 | 991 | 0.040 |
Why?
|
| Narcotic Antagonists | 1 | 2004 | 585 | 0.040 |
Why?
|
| Isomerism | 1 | 1998 | 197 | 0.040 |
Why?
|
| Densitometry | 1 | 1999 | 151 | 0.040 |
Why?
|
| Narcotics | 1 | 2001 | 335 | 0.040 |
Why?
|
| Stathmin | 1 | 2019 | 70 | 0.040 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2018 | 54 | 0.040 |
Why?
|
| Integrins | 1 | 2023 | 834 | 0.040 |
Why?
|
| Functional Laterality | 1 | 2005 | 2256 | 0.040 |
Why?
|
| Stilbamidines | 1 | 1998 | 43 | 0.040 |
Why?
|
| Neurokinin A | 2 | 1995 | 32 | 0.040 |
Why?
|
| PC12 Cells | 1 | 1998 | 317 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2004 | 1152 | 0.040 |
Why?
|
| Methylprednisolone | 1 | 1980 | 385 | 0.040 |
Why?
|
| Antigens, Differentiation | 1 | 2001 | 908 | 0.040 |
Why?
|
| Coenzymes | 1 | 2018 | 102 | 0.040 |
Why?
|
| Oligodendroglia | 1 | 2002 | 538 | 0.040 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 1998 | 77 | 0.040 |
Why?
|
| Thoracic Nerves | 1 | 1978 | 20 | 0.040 |
Why?
|
| Computational Biology | 1 | 2010 | 3509 | 0.040 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 1998 | 101 | 0.040 |
Why?
|
| Cholecystokinin | 1 | 2018 | 115 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 1970 | 0.040 |
Why?
|
| Cation Transport Proteins | 1 | 2001 | 327 | 0.040 |
Why?
|
| Salicylates | 2 | 1976 | 127 | 0.040 |
Why?
|
| Gene Library | 1 | 2001 | 1055 | 0.040 |
Why?
|
| Intercostal Nerves | 1 | 1978 | 28 | 0.040 |
Why?
|
| Germ-Free Life | 1 | 2018 | 186 | 0.040 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 1999 | 332 | 0.040 |
Why?
|
| Kynurenine | 1 | 2018 | 141 | 0.040 |
Why?
|
| Infusions, Parenteral | 2 | 1993 | 397 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2000 | 1057 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2019 | 3088 | 0.040 |
Why?
|
| Zebrafish | 2 | 2013 | 3005 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 7390 | 0.040 |
Why?
|
| Mutant Proteins | 1 | 2019 | 489 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2004 | 2048 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 2002 | 1170 | 0.040 |
Why?
|
| Linoleic Acids, Conjugated | 1 | 2017 | 15 | 0.040 |
Why?
|
| Cell Movement | 1 | 2009 | 5201 | 0.040 |
Why?
|
| Gene Targeting | 1 | 2001 | 837 | 0.040 |
Why?
|
| Receptors, Somatostatin | 1 | 1998 | 136 | 0.040 |
Why?
|
| Structure-Activity Relationship | 2 | 2013 | 3074 | 0.040 |
Why?
|
| Lumbosacral Region | 2 | 2003 | 293 | 0.040 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2018 | 115 | 0.040 |
Why?
|
| Mice, Mutant Strains | 2 | 2015 | 1748 | 0.040 |
Why?
|
| Homozygote | 3 | 2008 | 1776 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2015 | 54364 | 0.040 |
Why?
|
| Wounds, Penetrating | 1 | 1999 | 313 | 0.040 |
Why?
|
| Genome-Wide Association Study | 3 | 2012 | 12661 | 0.040 |
Why?
|
| Patients | 1 | 2004 | 906 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 1998 | 6520 | 0.040 |
Why?
|
| Photomicrography | 1 | 1996 | 71 | 0.040 |
Why?
|
| Gastroesophageal Reflux | 1 | 2004 | 821 | 0.040 |
Why?
|
| Brain Chemistry | 2 | 1998 | 960 | 0.040 |
Why?
|
| Linoleic Acids | 1 | 2016 | 39 | 0.030 |
Why?
|
| Binding Sites | 2 | 2003 | 6051 | 0.030 |
Why?
|
| Middle Aged | 16 | 2021 | 220603 | 0.030 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2015 | 4575 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2018 | 669 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2022 | 1088 | 0.030 |
Why?
|
| Immune Sera | 1 | 1997 | 605 | 0.030 |
Why?
|
| Adipocytes, Brown | 1 | 2017 | 150 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 5672 | 0.030 |
Why?
|
| Nitriles | 1 | 2002 | 971 | 0.030 |
Why?
|
| Rib Fractures | 1 | 1978 | 128 | 0.030 |
Why?
|
| Maze Learning | 1 | 2018 | 482 | 0.030 |
Why?
|
| Nitrogenous Group Transferases | 1 | 2016 | 4 | 0.030 |
Why?
|
| Fetus | 1 | 2004 | 1862 | 0.030 |
Why?
|
| Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) | 1 | 2016 | 11 | 0.030 |
Why?
|
| Perfusion | 1 | 2001 | 1373 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 4433 | 0.030 |
Why?
|
| Toxins, Biological | 1 | 1976 | 60 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2019 | 1540 | 0.030 |
Why?
|
| Acupuncture Therapy | 1 | 1980 | 486 | 0.030 |
Why?
|
| Cerebellar Diseases | 1 | 2018 | 220 | 0.030 |
Why?
|
| Ganglia, Sensory | 1 | 1995 | 19 | 0.030 |
Why?
|
| Kinetics | 2 | 2021 | 6370 | 0.030 |
Why?
|
| Immediate-Early Proteins | 1 | 1998 | 444 | 0.030 |
Why?
|
| Aged | 10 | 2021 | 169092 | 0.030 |
Why?
|
| Viral Proteins | 2 | 2003 | 1799 | 0.030 |
Why?
|
| Drug Resistance | 2 | 1998 | 1594 | 0.030 |
Why?
|
| Tachykinins | 1 | 1995 | 77 | 0.030 |
Why?
|
| Fluorescent Dyes | 3 | 1999 | 1901 | 0.030 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2016 | 187 | 0.030 |
Why?
|
| Pattern Recognition, Automated | 1 | 2021 | 994 | 0.030 |
Why?
|
| Obesity | 1 | 2017 | 12934 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2001 | 1336 | 0.030 |
Why?
|
| Alzheimer Disease | 2 | 2014 | 8603 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2016 | 293 | 0.030 |
Why?
|
| Depression | 1 | 2015 | 8132 | 0.030 |
Why?
|
| Indomethacin | 1 | 1995 | 323 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2012 | 15908 | 0.030 |
Why?
|
| Tissue Scaffolds | 1 | 2021 | 932 | 0.030 |
Why?
|
| Synovitis | 1 | 2016 | 217 | 0.030 |
Why?
|
| Genome | 1 | 2002 | 1737 | 0.030 |
Why?
|
| Sialoglycoproteins | 1 | 1995 | 315 | 0.030 |
Why?
|
| Stem Cells | 1 | 2007 | 3514 | 0.030 |
Why?
|
| Administration, Topical | 1 | 1996 | 703 | 0.030 |
Why?
|
| Genes, fos | 1 | 1994 | 175 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2013 | 41464 | 0.030 |
Why?
|
| Walking | 1 | 2021 | 1197 | 0.030 |
Why?
|
| Mutagenesis | 1 | 1998 | 1230 | 0.030 |
Why?
|
| Silver Staining | 1 | 1993 | 62 | 0.030 |
Why?
|
| Burns | 1 | 1985 | 1875 | 0.030 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 1995 | 299 | 0.030 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2016 | 431 | 0.030 |
Why?
|
| Cross-Over Studies | 3 | 2005 | 2079 | 0.030 |
Why?
|
| Cholestenones | 1 | 2013 | 6 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 12966 | 0.030 |
Why?
|
| Cell Membrane | 3 | 2007 | 3680 | 0.030 |
Why?
|
| Potassium Channels | 1 | 1996 | 537 | 0.030 |
Why?
|
| RNA | 3 | 2001 | 2713 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 2012 | 1759 | 0.030 |
Why?
|
| Acetylcholinesterase | 1 | 1993 | 156 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2001 | 2764 | 0.030 |
Why?
|
| Estrogens | 1 | 2020 | 1521 | 0.030 |
Why?
|
| Embryo Loss | 1 | 2013 | 55 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 1998 | 1202 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2016 | 852 | 0.030 |
Why?
|
| Glycogen | 1 | 1993 | 251 | 0.030 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 1992 | 55 | 0.030 |
Why?
|
| Thiolester Hydrolases | 1 | 1993 | 90 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2006 | 4569 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2019 | 1360 | 0.030 |
Why?
|
| Drug Administration Schedule | 2 | 2005 | 4845 | 0.030 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 16968 | 0.030 |
Why?
|
| Diazepam | 1 | 1993 | 215 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2018 | 1132 | 0.030 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1993 | 174 | 0.030 |
Why?
|
| Lectins | 2 | 2006 | 489 | 0.030 |
Why?
|
| Extracellular Space | 1 | 2014 | 562 | 0.030 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2016 | 620 | 0.030 |
Why?
|
| Carbenoxolone | 1 | 2012 | 8 | 0.030 |
Why?
|
| Quinolinium Compounds | 1 | 2012 | 10 | 0.030 |
Why?
|
| Class Ib Phosphatidylinositol 3-Kinase | 1 | 2012 | 42 | 0.030 |
Why?
|
| Atrophy | 1 | 1997 | 1632 | 0.030 |
Why?
|
| Wheat Germ Agglutinins | 1 | 1992 | 47 | 0.030 |
Why?
|
| Intraocular Pressure | 1 | 2018 | 1294 | 0.030 |
Why?
|
| Electron Transport | 1 | 2013 | 210 | 0.020 |
Why?
|
| Second Messenger Systems | 1 | 1993 | 202 | 0.020 |
Why?
|
| Tail | 2 | 1984 | 91 | 0.020 |
Why?
|
| Research | 1 | 2000 | 1977 | 0.020 |
Why?
|
| Streptozocin | 1 | 2012 | 193 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 1980 | 1819 | 0.020 |
Why?
|
| Arthropod Antennae | 1 | 2011 | 17 | 0.020 |
Why?
|
| Peptide Fragments | 2 | 2002 | 5109 | 0.020 |
Why?
|
| Optic Nerve | 1 | 2015 | 572 | 0.020 |
Why?
|
| Piperazines | 2 | 2013 | 2521 | 0.020 |
Why?
|
| Swine | 1 | 2021 | 5908 | 0.020 |
Why?
|
| Diaphragm | 1 | 2013 | 351 | 0.020 |
Why?
|
| Histidine | 1 | 2012 | 308 | 0.020 |
Why?
|
| Benzoxazoles | 1 | 2012 | 90 | 0.020 |
Why?
|
| Australia | 1 | 2015 | 1249 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2018 | 2639 | 0.020 |
Why?
|
| Benzazepines | 1 | 2013 | 310 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2021 | 1910 | 0.020 |
Why?
|
| Sirolimus | 1 | 2018 | 1533 | 0.020 |
Why?
|
| Biopsy | 1 | 2022 | 6763 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2016 | 1130 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2018 | 4010 | 0.020 |
Why?
|
| Presenilin-1 | 1 | 2014 | 660 | 0.020 |
Why?
|
| Injections, Intraventricular | 2 | 1981 | 225 | 0.020 |
Why?
|
| Fentanyl | 1 | 1993 | 433 | 0.020 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 1993 | 455 | 0.020 |
Why?
|
| Cell Transdifferentiation | 1 | 2011 | 186 | 0.020 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2012 | 433 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1994 | 2467 | 0.020 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2010 | 107 | 0.020 |
Why?
|
| Models, Molecular | 2 | 2019 | 5433 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2015 | 802 | 0.020 |
Why?
|
| Neuromuscular Diseases | 1 | 2013 | 258 | 0.020 |
Why?
|
| Electrodes | 1 | 1992 | 610 | 0.020 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2011 | 263 | 0.020 |
Why?
|
| Imidazoles | 2 | 2008 | 1175 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2013 | 410 | 0.020 |
Why?
|
| Parent-Child Relations | 1 | 2015 | 761 | 0.020 |
Why?
|
| Iron | 1 | 2018 | 1790 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2016 | 1113 | 0.020 |
Why?
|
| Anesthesia, Conduction | 1 | 1993 | 262 | 0.020 |
Why?
|
| Thorax | 1 | 1993 | 555 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2016 | 862 | 0.020 |
Why?
|
| Avoidance Learning | 1 | 2011 | 247 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2016 | 1602 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2006 | 2495 | 0.020 |
Why?
|
| Reflex, Monosynaptic | 2 | 1986 | 5 | 0.020 |
Why?
|
| Larva | 1 | 2011 | 509 | 0.020 |
Why?
|
| Body Temperature | 3 | 1980 | 780 | 0.020 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2013 | 258 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 2013 | 0.020 |
Why?
|
| Neoplasms | 1 | 2018 | 22131 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2011 | 982 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2018 | 2570 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2014 | 1079 | 0.020 |
Why?
|
| Hippocampus | 2 | 2015 | 3762 | 0.020 |
Why?
|
| Respiration | 2 | 2013 | 1656 | 0.020 |
Why?
|
| Quisqualic Acid | 1 | 1988 | 35 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 2013 | 665 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2008 | 6403 | 0.020 |
Why?
|
| Lasers | 1 | 2013 | 952 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2010 | 420 | 0.020 |
Why?
|
| Tyrosine | 1 | 2013 | 1440 | 0.020 |
Why?
|
| Survival Rate | 1 | 2022 | 12719 | 0.020 |
Why?
|
| Cell Division | 1 | 1995 | 4457 | 0.020 |
Why?
|
| Sleep | 1 | 2024 | 4764 | 0.020 |
Why?
|
| Cysteine | 1 | 2013 | 891 | 0.020 |
Why?
|
| Guanethidine | 1 | 2007 | 13 | 0.020 |
Why?
|
| Mammary Arteries | 1 | 2008 | 81 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2016 | 1985 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2015 | 14599 | 0.020 |
Why?
|
| Dexamethasone | 1 | 1995 | 1946 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2011 | 982 | 0.020 |
Why?
|
| Models, Animal | 1 | 2014 | 2108 | 0.020 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2015 | 1017 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 2803 | 0.020 |
Why?
|
| Hand | 2 | 2006 | 902 | 0.020 |
Why?
|
| Young Adult | 2 | 2017 | 59191 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 1992 | 1606 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 1988 | 389 | 0.020 |
Why?
|
| Sympathectomy | 1 | 2007 | 70 | 0.020 |
Why?
|
| Superoxides | 1 | 2008 | 387 | 0.020 |
Why?
|
| Hydroxydopamines | 3 | 1975 | 59 | 0.020 |
Why?
|
| Pressure | 2 | 1986 | 1150 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 2231 | 0.020 |
Why?
|
| Back Pain | 1 | 2010 | 545 | 0.020 |
Why?
|
| Fenclonine | 2 | 1977 | 16 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2012 | 2340 | 0.020 |
Why?
|
| Genome, Human | 1 | 2019 | 4421 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2021 | 64572 | 0.020 |
Why?
|
| Tocainide | 1 | 1985 | 5 | 0.020 |
Why?
|
| Antibodies | 1 | 1994 | 2413 | 0.020 |
Why?
|
| Perceptual Distortion | 1 | 2006 | 36 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2007 | 370 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 1992 | 1151 | 0.020 |
Why?
|
| Depression, Chemical | 1 | 1985 | 184 | 0.020 |
Why?
|
| Genes, gag | 1 | 2005 | 55 | 0.020 |
Why?
|
| Neuritis | 1 | 2005 | 35 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2022 | 6483 | 0.020 |
Why?
|
| Smad8 Protein | 1 | 2005 | 17 | 0.020 |
Why?
|
| Wnt1 Protein | 1 | 2006 | 121 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 1993 | 1718 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2012 | 1988 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 933 | 0.020 |
Why?
|
| Smad5 Protein | 1 | 2005 | 26 | 0.020 |
Why?
|
| Pancreas, Exocrine | 1 | 2005 | 48 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 2001 | 2261 | 0.020 |
Why?
|
| Disease Progression | 1 | 2002 | 13495 | 0.020 |
Why?
|
| Genetic Variation | 2 | 2013 | 6561 | 0.020 |
Why?
|
| Spermatocytes | 1 | 2005 | 40 | 0.020 |
Why?
|
| Mitochondria | 1 | 2018 | 3619 | 0.020 |
Why?
|
| Saphenous Vein | 1 | 2008 | 516 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2011 | 1186 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 2812 | 0.020 |
Why?
|
| Gene Deletion | 2 | 2005 | 2659 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 1986 | 555 | 0.010 |
Why?
|
| Burns, Chemical | 1 | 1985 | 123 | 0.010 |
Why?
|
| Kidney | 1 | 2000 | 7044 | 0.010 |
Why?
|
| Rats, Inbred F344 | 2 | 1996 | 826 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1993 | 2242 | 0.010 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2006 | 343 | 0.010 |
Why?
|
| Oncogene Proteins v-fos | 1 | 2003 | 15 | 0.010 |
Why?
|
| Receptors, Purinergic P2X3 | 1 | 2003 | 9 | 0.010 |
Why?
|
| Osteoarthritis | 1 | 2012 | 1063 | 0.010 |
Why?
|
| Membrane Microdomains | 1 | 2005 | 206 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 17878 | 0.010 |
Why?
|
| tau Proteins | 1 | 2014 | 2093 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 58919 | 0.010 |
Why?
|
| Mastectomy | 1 | 2012 | 1817 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1996 | 4512 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2018 | 42193 | 0.010 |
Why?
|
| Receptors, Prostaglandin E, EP1 Subtype | 1 | 2003 | 9 | 0.010 |
Why?
|
| Epididymis | 1 | 2005 | 227 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2003 | 310 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2009 | 3606 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 2 | 2007 | 4739 | 0.010 |
Why?
|
| Neuregulin-1 | 1 | 2003 | 135 | 0.010 |
Why?
|
| Stem Cell Transplantation | 1 | 2011 | 1600 | 0.010 |
Why?
|
| Adenosine Monophosphate | 1 | 1984 | 231 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2018 | 10429 | 0.010 |
Why?
|
| Lentivirus | 1 | 2005 | 507 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 2005 | 566 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 613 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 2916 | 0.010 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 1984 | 246 | 0.010 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2003 | 150 | 0.010 |
Why?
|
| Vinblastine | 1 | 1984 | 488 | 0.010 |
Why?
|
| Differential Threshold | 1 | 1982 | 80 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2004 | 23974 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2004 | 794 | 0.010 |
Why?
|
| Dyspnea | 1 | 1970 | 1347 | 0.010 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2007 | 610 | 0.010 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2004 | 502 | 0.010 |
Why?
|
| Quality of Life | 1 | 2023 | 13359 | 0.010 |
Why?
|
| Prognosis | 1 | 2022 | 29601 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2013 | 3115 | 0.010 |
Why?
|
| Secretory Rate | 1 | 1981 | 81 | 0.010 |
Why?
|
| Radiation Hybrid Mapping | 1 | 2001 | 18 | 0.010 |
Why?
|
| Auditory Perception | 1 | 2006 | 583 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2017 | 3802 | 0.010 |
Why?
|
| Uterus | 1 | 2005 | 649 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 1984 | 773 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 1 | 2014 | 3839 | 0.010 |
Why?
|
| Diuresis | 1 | 1981 | 106 | 0.010 |
Why?
|
| Physical Chromosome Mapping | 1 | 2001 | 183 | 0.010 |
Why?
|
| Ovary | 1 | 2005 | 959 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2001 | 420 | 0.010 |
Why?
|
| Introns | 1 | 2003 | 968 | 0.010 |
Why?
|
| DNA Probes | 1 | 2001 | 541 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2003 | 901 | 0.010 |
Why?
|
| Biological Transport | 2 | 1996 | 2089 | 0.010 |
Why?
|
| Bacillus thuringiensis | 2 | 1976 | 12 | 0.010 |
Why?
|
| Lung Diseases | 1 | 1970 | 1909 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 1980 | 613 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2004 | 1635 | 0.010 |
Why?
|
| Cats | 1 | 1981 | 974 | 0.010 |
Why?
|
| Dominance, Cerebral | 1 | 1981 | 623 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 4110 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 2001 | 586 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2001 | 430 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2008 | 2135 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 20556 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 2007 | 1248 | 0.010 |
Why?
|
| Medulla Oblongata | 1 | 1980 | 248 | 0.010 |
Why?
|
| Phenylalanine | 1 | 1980 | 365 | 0.010 |
Why?
|
| Callithrix | 1 | 1998 | 95 | 0.010 |
Why?
|
| Child | 2 | 2018 | 80089 | 0.010 |
Why?
|
| Ketamine | 1 | 2004 | 517 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2001 | 1692 | 0.010 |
Why?
|
| Periaqueductal Gray | 1 | 1998 | 110 | 0.010 |
Why?
|
| Prevalence | 1 | 2015 | 15702 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2012 | 6390 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2001 | 1989 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1998 | 574 | 0.010 |
Why?
|
| Forearm | 1 | 1979 | 427 | 0.010 |
Why?
|
| Neurosurgical Procedures | 1 | 2008 | 2067 | 0.010 |
Why?
|
| Skin Temperature | 1 | 1977 | 96 | 0.010 |
Why?
|
| Electricity | 1 | 1977 | 175 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 1998 | 1157 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2001 | 2178 | 0.010 |
Why?
|
| Octamer Transcription Factor-2 | 1 | 1996 | 7 | 0.010 |
Why?
|
| Sulfur Radioisotopes | 1 | 1996 | 113 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2006 | 1894 | 0.010 |
Why?
|
| Alleles | 1 | 2007 | 6861 | 0.010 |
Why?
|
| Ribs | 1 | 1977 | 252 | 0.010 |
Why?
|
| Nicotinic Acids | 1 | 1975 | 31 | 0.010 |
Why?
|
| Reserpine | 1 | 1975 | 63 | 0.010 |
Why?
|
| Protein Transport | 1 | 2001 | 1966 | 0.010 |
Why?
|
| Theophylline | 1 | 1975 | 131 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2008 | 3533 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2008 | 4172 | 0.010 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1975 | 174 | 0.010 |
Why?
|
| Face | 1 | 1981 | 1026 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 12043 | 0.010 |
Why?
|
| Cyprinidae | 1 | 1974 | 37 | 0.010 |
Why?
|
| Freeze Drying | 1 | 1994 | 101 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2001 | 2509 | 0.010 |
Why?
|
| Fura-2 | 1 | 1994 | 107 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1998 | 1848 | 0.010 |
Why?
|
| Salmonella typhi | 1 | 1976 | 198 | 0.010 |
Why?
|
| Cytidine | 1 | 1974 | 62 | 0.010 |
Why?
|
| Receptors, Kainic Acid | 1 | 1994 | 91 | 0.010 |
Why?
|
| Uridine | 1 | 1974 | 140 | 0.010 |
Why?
|
| Heart Rate | 1 | 1985 | 4181 | 0.010 |
Why?
|
| Kynurenic Acid | 1 | 1993 | 44 | 0.010 |
Why?
|
| Thoracic Surgery | 1 | 1980 | 722 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 26065 | 0.010 |
Why?
|
| Attention | 1 | 2004 | 2396 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 1993 | 229 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1996 | 1703 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2003 | 2896 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 1998 | 931 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2001 | 4611 | 0.010 |
Why?
|
| Electric Stimulation Therapy | 1 | 1977 | 626 | 0.010 |
Why?
|
| Ischemia | 1 | 1979 | 1885 | 0.010 |
Why?
|
| Virus Replication | 1 | 1998 | 2427 | 0.010 |
Why?
|
| Liver | 1 | 2006 | 7512 | 0.010 |
Why?
|
| Lung Compliance | 1 | 1970 | 200 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1975 | 1241 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 88247 | 0.000 |
Why?
|
| Elasticity | 1 | 1970 | 655 | 0.000 |
Why?
|
| Physical Exertion | 1 | 1970 | 668 | 0.000 |
Why?
|
| Spirometry | 1 | 1970 | 928 | 0.000 |
Why?
|
| Fractures, Bone | 1 | 1977 | 2045 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2012 | 80583 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1996 | 9171 | 0.000 |
Why?
|
| Oxygen | 1 | 1970 | 4226 | 0.000 |
Why?
|
| Biological Transport, Active | 1 | 1978 | 326 | 0.000 |
Why?
|
| Hypothalamus, Anterior | 1 | 1976 | 12 | 0.000 |
Why?
|
| Adenine Nucleotides | 1 | 1976 | 111 | 0.000 |
Why?
|
| Potassium | 1 | 1978 | 1311 | 0.000 |
Why?
|
| Adenosine Triphosphatases | 1 | 1978 | 835 | 0.000 |
Why?
|
| Protein Conformation | 1 | 1978 | 3965 | 0.000 |
Why?
|
| Energy Metabolism | 1 | 1978 | 2878 | 0.000 |
Why?
|